---
title: "Veradermics, Incorporated (MANE) Receives a Buy from LifeSci Capital"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293106327.md"
description: "LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on Veradermics, Incorporated (MANE) with a $170 price target. Katkhuda is a 5-star analyst in the Healthcare sector. The stock currently holds a Strong Buy consensus with an average price target of $169.20."
datetime: "2026-07-18T21:05:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293106327.md)
  - [en](https://longbridge.com/en/news/293106327.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293106327.md)
generator: "portal-rs"
---

# Veradermics, Incorporated (MANE) Receives a Buy from LifeSci Capital

In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on Veradermics, Incorporated, with a price target of $170.00.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

According to TipRanks, Katkhuda is a 5-star analyst with an average return of 32.4% and a 58.62% success rate. Katkhuda covers the Healthcare sector, focusing on stocks such as Disc Medicine, MoonLake Immunotherapeutics, and Eledon Pharmaceuticals.

Veradermics, Incorporated has an analyst consensus of Strong Buy, with a price target consensus of $169.20.

### Related Stocks

- [MANE.US](https://longbridge.com/en/quote/MANE.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [IRON.US](https://longbridge.com/en/quote/IRON.US.md)
- [MLTX.US](https://longbridge.com/en/quote/MLTX.US.md)
- [ELDN.US](https://longbridge.com/en/quote/ELDN.US.md)

## Related News & Research

- [Montanova Capital reports disposal of 750,000 Veradermics common shares worth $80.44 million](https://longbridge.com/en/news/296656843.md)
- [Veradermics CEO Reid Alexander Waldman disposes of common shares worth $7.24 million](https://longbridge.com/en/news/296284595.md)
- [Wedbush Keeps Their Buy Rating on IDEAYA Biosciences (IDYA)](https://longbridge.com/en/news/296510282.md)
- [88,309 Shares in UnitedHealth Group Incorporated $UNH Purchased by Allworth Financial LP](https://longbridge.com/en/news/296749626.md)
- [Alignment Healthcare to present at Baird 2026 Global Healthcare Conference](https://longbridge.com/en/news/296487994.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**